Sign In

Shiva Bhowmik

Founder + COO at Trio Pharmaceutials, Inc.

Professional Background

Dr. Shiva Bhowmik is an esteemed drug developer who has dedicated his career to creating innovative therapies targeting diseases with significant unmet medical needs. As a co-founder and Chief Operating Officer at Trio Pharmaceuticals, Inc., Dr. Bhowmik is at the helm of developing cutting-edge solutions that aim to resolve some of the most pressing health challenges faced by patients today. His commitment to advancing medicine and improving lives reflects a combination of academic expertise and industry experience.

Previously, Dr. Bhowmik served as a Partner at InVenture Consultants, where he utilized his extensive knowledge to guide projects through the drug development process, ensuring that innovative ideas were translated into viable therapeutic options. His experience includes a notable position as Antibody Therapeutic Development Manager at ImmunoBrain Checkpoint, Ltd., where he led significant advancements in antibody-based treatments. As Program Leader at Ambrx, he managed strategic projects aimed at developing novel therapeutics, enhancing his leadership and project management skills.

Dr. Bhowmik's career pathways have also included consulting roles, such as at Drug Discovery for Tropical Diseases, where he contributed to important initiatives targeting neglected diseases. His foundational research roles at renowned institutions, including The Joint Center for Structural Genomics and the Genomics Institute of the Novartis Research Foundation, provided him with a robust research background that underpins his work in the pharmaceutical industry. His early academic career as a Graduate Research Assistant at Purdue University further solidified his expertise in biochemistry, biophysics, and molecular biology.

Education and Achievements

Dr. Bhowmik's educational journey laid a strong foundation for his successful career in drug development. He earned a Master of Technology degree in Biotechnology from the prestigious Indian Institute of Technology, Kharagpur, a program known for its rigorous curriculum and emphasis on innovation. Following this, he pursued a Ph.D. in Biochemistry, Biophysics, and Molecular Biology at Purdue University, where he honed his research skills and deepened his understanding of the molecular mechanisms of diseases.

Throughout his career, Dr. Bhowmik has been recognized for his contributions to biotechnology and drug development. His scholarly work and practical applications have greatly influenced therapeutic strategies and improved scientific understanding in his area of expertise.

His work is not just limited to laboratory research; he has actively engaged in translating complex scientific concepts into practical applications that have the potential to transform patient care and therapeutic effectiveness. This connection between academic knowledge and real-world application is a hallmark of Dr. Bhowmik's approach to drug development.

Achievements

Dr. Shiva Bhowmik's professional journey is marked by numerous achievements that underline his significance in the biotechnology landscape. As a founder and COO at Trio Pharmaceuticals, one of his notable achievements is steering the company through various stages of development, from initial concept to execution of strategies that lead to the discovery of impactful therapies.

His previous leadership roles have equipped him with invaluable experience that enhances his capacity to oversee projects effectively. At ImmunoBrain Checkpoint, Ltd., he played a crucial role in therapeutic development, and his contributions have likely affected many lives positively by promoting advanced treatments.

Dr. Bhowmik’s insights into the pharmaceutical industry are further exemplified through his involvement in consulting for drug discovery aimed at combating tropical diseases, showcasing his commitment to addressing global health challenges. His academic prowess, combined with his professional journey, makes him a distinguished figure in the field of drug development, with a profound impact on the future of therapeutic progress.

Tags

drug development

biotechnology

biochemistry

molecular biology

Indian Institute of Technology Kharagpur

Purdue University

Trio Pharmaceuticals

InVenture Consultants

ImmunoBrain Checkpoint

Ambrx

therapeutic development

tropical diseases

structural genomics

Novartis

Scripps Research Institute

Related Questions

How did Shiva Bhowmik transition from academia to the pharmaceutical industry?
What inspired Shiva Bhowmik to focus on developing therapies for diseases with unmet medical needs?
In what ways has Shiva Bhowmik's educational background contributed to his success as a drug developer?
What innovative projects is Shiva Bhowmik currently pursuing at Trio Pharmaceuticals, Inc.?
How does Shiva Bhowmik’s experience as a researcher at The Scripps Research Institute influence his approach to drug development?
Shiva Bhowmik
Add to my network

Location

San Diego County, California, United States